Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This safety pilot study evaluates the effect of hydroxychloroquine on preventing recurrent cardiovascular events among myocardial infarction patients. Half of the participants will receive hydroxychloroquine, whereas the other half will receive placebo during six months.
Epistemonikos ID: 11ffd23b9b39e9c0e8492d47287dbb1cb60b72e9
First added on: Mar 24, 2022